T39.1X
Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T39.1X pertains to cases involving poisoning, adverse effects, or underdosing of medications that are 4-Aminophenol derivatives. These medications include common pain relievers and fever reducers such as acetaminophen (paracetamol). While these drugs are generally safe when used correctly, overdose or adverse reactions can lead to serious health issues requiring medical attention. This article provides an overview of the causes, symptoms, diagnosis, and treatment options related to this condition.
Causes & Symptoms
Clinical Causes: Accidental overdose of 4-Aminophenol derivative medications, often due to misjudging the correct dosage. Intentional overdose in cases of self-harm or suicide attempts. Unsuitable dosing in individuals with liver problems or other contraindications. Use of multiple medications containing 4-Aminophenol derivatives without proper medical guidance. Underdosing or skipping doses, leading to ineffective treatment or adverse effects.
Key Symptoms: Nausea and vomiting Loss of appetite Confusion or weakness Jaundice (yellowing of the skin and eyes) Abdominal pain, especially in the upper right quadrant Dark urine Fatigue and malaise Signs of liver damage such as bleeding tendencies or abdominal swelling
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily based on a detailed medical history and physical examination. Healthcare providers may perform the following tests to confirm poisoning and evaluate severity:
Treatment Protocols: Prompt treatment is essential for poisoning cases involving 4-Aminophenol derivatives. Medical interventions may include:
Clinical Advice & FAQs
Billing Guidance
Is T39.1X a billable ICD-10 code?
Yes, T39.1X is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T39.1X?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives and any associated comorbidities for accurate reporting.
Cite this Clinical Reference